Pregabalin (Lyrica) + Placebo
Phase 1Completed 0 watching 0 views this week💤 Quiet
32
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Nerve Pain
Conditions
Nerve Pain
Trial Timeline
May 1, 2008 → Feb 1, 2009
NCT ID
NCT00654940About Pregabalin (Lyrica) + Placebo
Pregabalin (Lyrica) + Placebo is a phase 1 stage product being developed by Pfizer for Nerve Pain. The current trial status is completed. This product is registered under clinical trial identifier NCT00654940. Target conditions include Nerve Pain.
Hype Score Breakdown
Clinical
10
Activity
5
Company
9
Novelty
3
Community
2
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01057693 | Phase 3 | Completed |
| NCT00654940 | Phase 1 | Completed |
| NCT00646451 | Phase 1 | Completed |
Competing Products
11 competing products in Nerve Pain
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| QUTENZA + Lidocaine + Tramadol | Astellas Pharma | Approved | 85 |
| Bupivacaine Liposome Injection + Bupivacaine Hydrochloride Injection | Jiangsu Hengrui Medicine | Phase 2 | 52 |
| AZD2423 + AZD2423 + Placebo | AstraZeneca | Phase 2 | 52 |
| Selumetinib + Sirolimus | AstraZeneca | Phase 2 | 52 |
| Pembrolizumab | Merck | Phase 2 | 52 |
| imatinib mesylate | Novartis | Phase 2/3 | 65 |
| everolimus + bevacizumab | Novartis | Phase 2 | 52 |
| Zyvox - linezolid + Matched control | Pfizer | Phase 3 | 76 |
| Nivolumab + Ipilimumab | Bristol Myers Squibb | Phase 1 | 32 |
| Tisseel® | Baxter | Pre-clinical | 20 |
| Processed Nerve Allograft (human) | Axogen | Phase 3 | 72 |